node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
APP | HTR2A | ENSECAP00000019519 | ENSECAP00000032673 | Amyloid beta precursor protein. | 5-hydroxytryptamine receptor 2A. | 0.402 |
APP | INS | ENSECAP00000019519 | ENSECAP00000022114 | Amyloid beta precursor protein. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.585 |
APP | TREM2 | ENSECAP00000019519 | ENSECAP00000012909 | Amyloid beta precursor protein. | Triggering receptor expressed on myeloid cells 2. | 0.598 |
GUCA1A | GUCA1B | ENSECAP00000051243 | ENSECAP00000043913 | Guanylate cyclase activator 1A. | Guanylate cyclase activator 1B. | 0.742 |
GUCA1A | GUCA1C | ENSECAP00000051243 | ENSECAP00000016527 | Guanylate cyclase activator 1A. | Guanylate cyclase activator 1C. | 0.528 |
GUCA1B | GUCA1A | ENSECAP00000043913 | ENSECAP00000051243 | Guanylate cyclase activator 1B. | Guanylate cyclase activator 1A. | 0.742 |
GUCA1B | GUCA1C | ENSECAP00000043913 | ENSECAP00000016527 | Guanylate cyclase activator 1B. | Guanylate cyclase activator 1C. | 0.933 |
GUCA1C | GUCA1A | ENSECAP00000016527 | ENSECAP00000051243 | Guanylate cyclase activator 1C. | Guanylate cyclase activator 1A. | 0.528 |
GUCA1C | GUCA1B | ENSECAP00000016527 | ENSECAP00000043913 | Guanylate cyclase activator 1C. | Guanylate cyclase activator 1B. | 0.933 |
GUCA2A | GUCA2B | ENSECAP00000012956 | ENSECAP00000015604 | Guanylate cyclase activator 2A. | Guanylate cyclase activator 2B. | 0.760 |
GUCA2B | GUCA2A | ENSECAP00000015604 | ENSECAP00000012956 | Guanylate cyclase activator 2B. | Guanylate cyclase activator 2A. | 0.760 |
HTR2A | APP | ENSECAP00000032673 | ENSECAP00000019519 | 5-hydroxytryptamine receptor 2A. | Amyloid beta precursor protein. | 0.402 |
IGF1 | INS | ENSECAP00000033255 | ENSECAP00000022114 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.995 |
IGF1 | INSR | ENSECAP00000033255 | ENSECAP00000008032 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | Tyrosine-protein kinase receptor. | 0.996 |
IGF1 | PPARGC1A | ENSECAP00000033255 | ENSECAP00000035922 | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | PPARG coactivator 1 alpha. | 0.510 |
INS | APP | ENSECAP00000022114 | ENSECAP00000019519 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Amyloid beta precursor protein. | 0.585 |
INS | IGF1 | ENSECAP00000022114 | ENSECAP00000033255 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | 0.995 |
INS | INSR | ENSECAP00000022114 | ENSECAP00000008032 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Tyrosine-protein kinase receptor. | 0.999 |
INS | PPARGC1A | ENSECAP00000022114 | ENSECAP00000035922 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | PPARG coactivator 1 alpha. | 0.698 |
INSR | IGF1 | ENSECAP00000008032 | ENSECAP00000033255 | Tyrosine-protein kinase receptor. | Insulin-like growth factor I; The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]- 2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation. Ca(2+)-dependent exo [...] | 0.996 |